Compared with the control group, the PCOS-IR group exhibited a broad spectrum of metabolic and endocrine changes, such as significantly elevated TG levels, AMH, and testosterone, an increased LH to FSH ratio and notably decreased FSH, and PRL levels. This evidence concerns the gene AMH and polycystic ovary syndrome.